Burney Co. Makes New Investment in Pediatrix Medical Group, Inc. $MD

Burney Co. purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) during the first quarter, Holdings Channel reports. The fund purchased 52,796 shares of the company’s stock, valued at approximately $1,129,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in MD. Global Retirement Partners LLC raised its holdings in Pediatrix Medical Group by 68,250.0% in the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after buying an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC bought a new stake in Pediatrix Medical Group during the 4th quarter worth approximately $30,000. Eurizon Capital SGR S.p.A. bought a new stake in Pediatrix Medical Group during the 4th quarter worth approximately $33,000. Blue Trust Inc. acquired a new position in Pediatrix Medical Group in the 4th quarter valued at approximately $37,000. Finally, TD Private Client Wealth LLC acquired a new position in Pediatrix Medical Group in the 4th quarter valued at approximately $39,000. 97.71% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.80% of the stock is owned by corporate insiders.

Pediatrix Medical Group Trading Down 0.5%

MD opened at $26.73 on Thursday. Pediatrix Medical Group, Inc. has a twelve month low of $11.84 and a twelve month high of $27.94. The company has a fifty day moving average of $23.43 and a 200-day moving average of $21.98. The stock has a market cap of $2.19 billion, a PE ratio of 12.97 and a beta of 0.66. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.45.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. The business had revenue of $476.20 million for the quarter, compared to analyst estimates of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. Pediatrix Medical Group’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.33 earnings per share. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on MD shares. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a report on Monday, April 13th. Mizuho set a $24.00 target price on Pediatrix Medical Group in a research report on Friday, May 8th. UBS Group lifted their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $22.50.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.